Scientists hope that by targeting specific protein, they will be able to develop treatments for patients with metastasized cancers resistant to chemotherapy and immunotherapy

Shaare Zedek Medical Center participates in international long-term clinical trial of Denosumab, which investigators say may offer medical alternative to preventive mastectomy